Subscribe

Sam Falsetti, Cambridge BioMarketing, an Ashfield company

Articles by Sam Falsetti, Cambridge BioMarketing, an Ashfield company

Rare disease patient support

ByNareda Mills, Ashfield U.S.A,Sam Falsetti, Cambridge BioMarketing, an Ashfield company

August 6th 2018

Rare diseases are hard to treat; supporting the patient can be even more challenging

Latest Updated Articles

Rare disease patient support
Published: August 6th 2018 | Updated:

Trending on Pharmaceutical Commerce

Health Resources & Services Administration Announces Initial Drugs Apart of 340B Rebate Model Pilot Program

Improving Pharma Launch Performance With AI-Driven Decision Support

From Prescribing to Pick Up: Navigating the Access & Affordability Landscape

© 2025 MJH Life Sciences^®

All rights reserved.